Cefazolin Dosing in Severe Renal Impairment (GFR 19 mL/min)
For a patient with GFR 19 mL/min, administer cefazolin 500 mg every 12 hours for most infections, or 1 gram every 12 hours for severe/life-threatening infections.
Dosing Rationale
The FDA label for cefazolin does not provide explicit dosing for GFR <10 mL/min, but pharmacokinetic studies demonstrate that cefazolin is primarily renally excreted (60-80% unchanged in urine within 24 hours), necessitating substantial dose reduction in severe renal impairment 1.
Pharmacokinetic Considerations
- Normal half-life: 1.8-2.2 hours 1, 2
- Severe renal impairment half-life: Dramatically prolonged to 32.1 hours in patients with GFR <20 mL/min 3
- Drug accumulation risk: The 15-fold increase in half-life creates significant risk of drug accumulation and toxicity without dose adjustment 2, 3
Evidence-Based Dosing Algorithm
For GFR 15-29 mL/min (Stage 4 CKD):
- Loading dose: 1 gram initially to achieve therapeutic levels rapidly 2
- Maintenance dose for moderate infections: 500 mg every 12 hours 2, 3
- Maintenance dose for severe infections: 1 gram every 12 hours (maximum) 4
- Dosing interval: Must be extended to at least 12 hours, potentially 24 hours for less severe infections 2, 3
The linear correlation between elimination rate and creatinine clearance (Ke = 0.022 + 0.0028 × CrCl) allows precise calculation: at GFR 19, the elimination constant is dramatically reduced, requiring both dose reduction and interval extension 2.
Clinical Monitoring Requirements
Essential monitoring parameters:
- Serum cefazolin levels: Target trough concentrations of 4-8 mg/L for most infections; higher targets (up to 40 mg/L) may be needed for serious infections like endocarditis 5, 6
- Renal function: Monitor creatinine every 2-3 days during therapy, as acute changes require immediate dose adjustment 5
- Clinical response: Assess for treatment failure indicators (persistent fever, worsening infection markers) within 48-72 hours 7
Critical Pitfalls to Avoid
Do not use standard dosing regimens (1-2 grams every 8 hours) in patients with GFR <30 mL/min, as this results in toxic drug accumulation with peak levels 1.5-5 times higher than in patients with normal renal function 3.
Avoid underdosing: While dose reduction is necessary, inadequate dosing (e.g., 500 mg every 24 hours) may fail to maintain concentrations above the MIC for methicillin-susceptible Staphylococcus aureus (MSSA) and gram-negative organisms 8, 6.
Consider continuous infusion: For severe infections requiring higher exposure, continuous infusion (after loading dose) provides more consistent drug levels and improved target attainment compared to intermittent bolus dosing in renal impairment 5, 6.
Dialysis Considerations
If the patient progresses to dialysis: